JKHY — Jack Henry & Associates, Inc.

Wall Street is constructive but not euphoric: the analyst consensus is a Moderate Buy (13 buy / 10 hold / 0 sell) with a $186 consensus target, and shares rallied ~25.7% over the trailing three months (as of 2026-09-13). That is offset by a split of recent actions - D.A. Davidson reiterated Buy with a $198 target on 2026-09-02, while Piper Sandler initiated Neutral with a $171 target on 2026-09-11 - and by a 6-month return of -4.5% and a -2.7% past week, so the tape is choppy rather than trending. News flow is balanced: record FY26 (revenue +7.1% to $2.54B, EPS +11.9% to $6.98), 58 competitive core wins and a new Celtic Bank deal (2026-09-08) versus a disclosed cybersecurity incident (2026-08-31).

Top-line growth has been steady in the mid-single to high-single digits but the newest quarter broke the pattern. FY26 revenue rose from $644.7M (Q1) to $633.1M (Q4), and YoY growth by quarter was +7.3%, +7.9%, +8.7%, then just +2.9% in fiscal Q4 (2026-06-30) - a clear deceleration. Operating margin compressed steadily through the fiscal year: 28.6% in Q1 FY26 ($184.1M/$644.7M), 25.7% in Q2, 24.4% in Q3, and 21.0% in Q4 ($132.7M/$633.1M), versus 25.3% in the year-ago Q4. That drop reflects both a gross-margin dip (44.1% to 42.3% YoY in Q4) and R&D up ~17% YoY ($42.6M to $49.8M). Diluted EPS fell to $1.57 in Q4 from $1.75 a year earlier even as full-year EPS rose to $6.97 from $6.24. Cash generation is the strongest part of the story: FY26 free cash flow was $694.9M versus $588.1M in FY25 (+18%), and the accruals ratio of -6.09% (as of 2026-06-30) confirms earnings are cash-backed. Net read: a stable, high-margin compounder whose most recent quarter inflected softer on both revenue and margin - one quarter isn't structural, but it is the key thing to watch.

As of 2026-09-13, JKHY trades at 23.08x trailing EPS of $6.979 and ~21.9x the next-FY consensus EPS of $7.346, versus a 5-year average trailing P/E of 29.89 - so it is genuinely cheap relative to its own history (the deterministic overlay scores this 'Cheap vs. its own history'). P/S of 4.52x is below the 5-year average of 5.5x, and EV/EBITDA is 13.5x. On absolute terms it is not a bargain: PEG of ~1.98, P/B of 5.66x, and a 1.46% dividend yield are all 'quality at a fair-to-full price.' The de-rating from ~30x to ~23x reflects slower growth and a more mature core, so the discount is partly earned rather than purely an opportunity.

The market is paying ~22x forward earnings for a company guiding toward only ~5-8% EPS growth - roughly a market multiple, not a growth premium. That means upside has to come from either estimate revisions (the Q4 slowdown reversing, an upbeat Investor Day, or continued upmarket core wins converting to revenue) or multiple mean-reversion toward the mid-20s. If instead the Q4 margin compression and +2.9% revenue growth prove structural, the current multiple is arguably still full. Net: earnings look fairly priced today; you are not paid much for waiting unless the growth inflection improves.

As of 2026-09-13, RSI(14) was 49.39 - dead neutral, neither overbought nor oversold. Price of $161.12 sat 1.89% below its 20-day SMA but 2.67% above its 50-day and 0.82% above its 200-day, i.e., range-bound around a cluster of moving averages after a strong 3-month run (+25.65%) that is now cooling (1-week -2.73%). There is no timing edge here; a pullback into the $150s or a decisive reclaim of the 20-day would offer better risk/reward than chasing a neutral tape into the 2026-09-15 Investor Day.

• Interest-rate/net-interest-margin pressure on community banks and credit unions cuts both ways: it drives demand for efficiency and non-interest-income technology but can also freeze discretionary core-conversion budgets.
• The multi-year bank core-modernization cycle - legacy systems migrating to private/public cloud - is a durable tailwind that JKHY is positioned to capture.
• Intensifying regulatory scrutiny of cybersecurity, third-party vendor risk, and data protection raises compliance costs but favors entrenched, well-capitalized vendors like JKHY.
• Ongoing community-bank and credit-union consolidation shrinks the customer count but increases average deal size; JKHY won 14 core deals with institutions over $1B in assets in FY26, evidence it can win upmarket.
• Fintech and larger-peer competition (FIS, Fiserv) plus broad software-sector multiple discipline keep the valuation ceiling in check, despite JKHY's low beta (0.564).

• Investor Day on 2026-09-15 - multi-year strategy, margin-expansion targets, and AI roadmap could reset growth expectations or, if vague, disappoint.
• Q1 FY2027 earnings (expected early-to-mid November 2026) - the first read on whether the fiscal Q4 revenue deceleration (+2.9%) and margin compression were one-offs or a trend.
• Continued upmarket core and payments wins (58 in FY26) and new logos such as Celtic Bank (2026-09-08) feeding the backlog.
• Analyst estimate and rating revisions around the Investor Day (D.A. Davidson at $198 Buy versus Piper Sandler at $171 Neutral).
• Clarity on the 2026-08-31 cybersecurity incident - confirmation of limited scope would remove an overhang.

• Fiscal Q4 FY26 revenue growth decelerated to +2.9% YoY and operating margin fell to 21.0% from 25.3%; if this proves structural rather than timing/mix, forward estimates and the multiple both face downside.
• Structural growth is only ~7% revenue / high-single-digit EPS, which may keep the stock de-rated versus its historical ~30x P/E.
• Absolute valuation is not cheap (P/B 5.66x, P/S 4.52x, PEG ~2.0), leaving little cushion if growth slows further.
• Cybersecurity and operational risk, underscored by the 2026-08-31 incident disclosure, in an industry where trust is the product.
• Customer concentration risk from community-bank consolidation and budget caution, plus competitive pressure from FIS, Fiserv and cloud-native fintech entrants.

JKHY is a genuinely high-quality, essentially debt-free (D/E 0.019), wide-moat-style financial software compounder - 25% operating margins, 18% ROIC, strong cash conversion, a 1.5% dividend - trading at a real discount to its own history (23x vs ~30x) on a ~6% free-cash-flow yield. The catch is that growth is only mid-single-digit and the newest quarter inflected softer on both revenue and margin. This is a reasonable accumulate-on-weakness holding, not a screaming buy at $161; the 2026-09-15 Investor Day and the Q1 FY27 print are the proof points that decide whether the discount closes or persists.

Two cross-checks converge near $184: (1) a fair forward P/E of 25x - a discount to the 5-year average trailing P/E of 29.89 to reflect the slower ~7% growth and the fiscal-Q4 deceleration, but a premium to the current ~22x for the debt-free balance sheet, 24.9% operating margin, and 18% ROIC - applied to next-FY consensus EPS of $7.346 gives ~$184; and (2) a ~5.3% required FCF yield on FY2026 free cash flow of $694.9M ($9.78/share on ~71.1M shares) also yields ~$184.